For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Engerix™ Group | Subjects received 4 doses of Hepatitis B (HBV) vaccine (Months 0, 1, 2 \& 12). | None | None | 2 | 76 | 73 | 76 | View |
| Cervarix™ & Engerix™ Group | Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™) (Months 0, 1 \& 6) and 4 doses of Hepatitis B (Engerix™) vaccine (Months 0, 1, 2 \& 12). | None | None | 2 | 76 | 76 | 76 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abortion spontaneous complete | NON_SYSTEMATIC_ASSESSMENT | Pregnancy, puerperium and perinatal conditions | MedDRA 10.0 | View |
| Graves-Basedow's disease | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDRA 10.0 | View |
| Endometriosis | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 10.0 | View |
| Gastroenteritis viral | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 10.0 | View |
| Type 1 diabetes mellitus | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 10.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Pain at injection site | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Redness at injection site | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Swelling at injection site | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Gastrointestinal symptom | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 10.0 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Rash | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Temperature | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 10.0 | View |
| Upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 10.0 | View |
| Dysmenorrhoea | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 10.0 | View |
| Cystitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 10.0 | View |
| Nasopharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 10.0 | View |
| Oropharyngeal pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 10.0 | View |
| Rhinitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 10.0 | View |
| Abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 10.0 | View |
| Cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 10.0 | View |
| Influenza like illness | NON_SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 10.0 | View |
| Pharyngitis | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 10.0 | View |